ID	PFS	OS	PFS_CENSOR	OS_CENSOR	CD8_brown_High	CD8_brown_Low	CD8_brown_ratio	CD8_brown_binary_ratio	CD8_TEM_ratio	CD8_TEM_binary_ratio	age	histology	LoT	ECOG	PDL1_binary	PDL1_score	Genomic_alterations	sex	regimen	IO_ID
ID001	489	489	1	1	437	348	0.557	low	0.609	high	79.1	LUSC	1	1	0	40	0	1	Pembrolizumab	IO_SC_001
ID002	113	445	1	1	208	204	0.505	low	0.568	high	48.7	LUAD	1	1	1	90	1	1	Pembrolizumab	IO_SC_002
ID003	478	478	1	1	247	213	0.537	low	0.626	high	82.6	LUAD	2	2	0	0	0	1	Atezolizumab	IO_SC_004
ID004	68	467	1	1	307	227	0.575	low	0.627	high	69.3	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_006
ID005	760	1089	0	1	336	56	0.857	high	0.702	high	81.5	LUAD	1	1	1	90	0	1	Atezolizumab	IO_SC_007
ID006	2082	2082	0	0	229	610	0.273	low	0.358	low	40.5	LUSC	1	0	0	25	0	2	Nivolumab	IO_SC_008
ID007	42	1106	1	1	548	367	0.599	low	0.591	high	59.8	LUAD	1	1	1	80	0	1	Nivolumab	IO_SC_009
ID008	49	56	1	1	479	178	0.729	high	0.75	high	76.1	LUAD	6	2	1	70	1	1	Pembrolizumab	IO_SC_010
ID009	681	2647	1	0	736	523	0.585	low	0.546	high	51.5	LUAD	1	1	0	0	0	1	Nivolumab	IO_SC_012
ID010	131	520	0	1	168	386	0.303	low	0.39	low	63.6	LUAD	1	1	0	0	0	1	Atezolizumab	IO_SC_013
ID011	178	683	1	1	223	370	0.376	low	0.479	low	45.7	LUAD	1	1	0	10	0	1	Pembrolizumab	IO_SC_015
ID012	257	369	1	1	174	442	0.282	low	0.45	low	69.3	LUSC	1	1	0	10	0	1	Pembrolizumab	IO_SC_016
ID013	90	219	1	1	399	165	0.707	high	0.702	high	48.9	LUSC	1	1	0	<1	0	1	Pembrolizumab	IO_SC_017
ID014	129	816	1	1	242	222	0.522	low	0.595	high	70.8	LUSC	1	1	0	1	0	1	Pembrolizumab	IO_SC_018
ID015	41	82	1	1	219	49	0.817	high	0.672	high	65.9	LUSC	2	2	1	100	0	1	Pembrolizumab	IO_SC_019
ID016	195	371	1	1	28	100	0.219	low	0.227	low	70.1	LUSC	1	1	1	50	0	1	Pembrolizumab	IO_SC_021
ID017	81	283	1	1	204	132	0.607	low	0.75	high	69.5	LUSC	1	1	0	5	1	2	Pembrolizumab	IO_SC_022
ID018	29	79	1	1	83	178	0.318	low	0.268	low	61.2	LUSC	1	1	0	10	0	1	Pembrolizumab	IO_SC_023
ID019	1270	1871	1	0	273	625	0.304	low	0.394	low	70.5	LUAD	0	1	1	50	0	1	Pembrolizumab	IO_SC_027
ID020	210	431	1	1	85	290	0.227	low	0.243	low	61.6	LUAD	1	1	1	100	0	1	Nivolumab	IO_SC_028
ID021	1510	1510	1	1	255	111	0.697	low	0.577	high	39.4	Others	0	1	1	80	0	1	Nivolumab	IO_SC_029
ID022	87	1830	1	0	242	253	0.489	low	0.586	high	71.4	LUAD	1	1	1	10	0	1	Pembrolizumab	IO_SC_031
ID023	1468	1513	1	1	354	324	0.522	low	0.5	low	62.1	LUAD	0	1	1	80	1	1	Pembrolizumab	IO_SC_032
ID024	59	500	1	1	399	235	0.629	low	0.595	high	58.8	LUSC	2	1	0	5	0	1	Pembrolizumab	IO_SC_033
ID025	709	1475	1	1	163	262	0.384	low	0.409	low	70	Others	1	1	1	60	0	1	Pembrolizumab	IO_SC_035
ID026	579	1875	1	0	244	266	0.478	low	0.42	low	54.7	LUAD	1	1	0	10	0	1	Nivolumab	IO_SC_036
ID027	441	441	1	1	75	94	0.444	low	0.781	high	69.6	Others	1	1	0	10	1	1	Nivolumab	IO_SC_037
ID028	1928	1928	0	0	45	143	0.239	low	0.926	high	65.9	LUAD	1	1	1	100	1	1	Pembrolizumab	IO_SC_038
ID029	37	73	1	1	206	339	0.378	low	0.486	low	57.1	LUAD	2	1	1	50	1	1	Pembrolizumab	IO_SC_040
ID030	294	462	1	1	370	116	0.761	high	0.698	high	32.8	LUAD	9	1	0	0	1	1	Pembrolizumab	IO_SC_042
ID031	91	1218	1	1	362	309	0.539	low	0.559	high	73.7	Others	1	1	1	80	0	1	Pembrolizumab	IO_SC_043
ID032	37	1797	1	0	231	300	0.435	low	0.369	low	64.3	LUSC	1	1	0	5	0	1	Pembrolizumab	IO_SC_045
ID033	1863	1863	0	0	523	399	0.567	low	0.561	high	60.4	LUSC	1	1	1	70	0	1	Pembrolizumab	IO_SC_046
ID034	250	697	1	1	356	57	0.862	high	0.746	high	62.2	LUSC	0	1	1	60	0	1	Pembrolizumab	IO_SC_048
ID035	1548	1609	1	1	679	372	0.646	low	0.664	high	78.9	Others	0	0	1	50	0	1	Pembrolizumab	IO_SC_050
ID036	123	247	1	1	840	198	0.809	high	0.709	high	53.8	LUAD	1	1	1	20	0	1	Pembrolizumab	IO_SC_051
ID037	35	246	1	1	183	44	0.806	high	0.714	high	58.6	LUSC	1	1	1	30	0	1	Nivolumab	IO_SC_052
ID038	1081	1328	1	1	338	356	0.487	low	0.399	low	55.2	LUAD	0	1	1	50	0	1	Pembrolizumab	IO_SC_054
ID039	24	80	1	1	756	135	0.848	high	0.751	high	70.5	LUSC	2	1	0	5	0	1	Pembrolizumab	IO_SC_056
ID040	28	334	1	1	336	328	0.506	low	0.373	low	67.9	LUAD	1	1	0	<1	0	1	Atezolizumab	IO_SC_059
ID041	1785	1785	0	0	171	133	0.563	low	0.671	high	73	LUSC	1	1	1	50	0	1	Pembrolizumab	IO_SC_060
ID042	1365	1601	0	1	89	303	0.227	low	0.219	low	48.8	LUAD	1	1	1	100	1	1	Pembrolizumab	IO_SC_063
ID043	42	265	1	1	146	214	0.406	low	0.442	low	66.8	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_064
ID044	187	201	1	1	375	512	0.423	low	0.662	high	63.7	LUSC	1	1	0	10	0	1	Atezolizumab	IO_SC_065
ID045	35	117	1	1	151	106	0.588	low	0.482	low	67.5	LUSC	1	1	0	0	0	1	Pembrolizumab	IO_SC_066
ID046	35	617	1	1	57	153	0.271	low	0.248	low	60.7	LUSC	1	1	0	NA	0	1	Atezolizumab	IO_SC_067
ID047	43	239	1	1	281	159	0.639	low	0.564	high	78.6	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_068
ID048	43	139	1	1	105	40	0.724	high	0.586	high	77.1	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_069
ID049	1697	1697	0	0	284	250	0.532	low	0.605	high	65	LUAD	1	1	0	10	0	1	Pembrolizumab	IO_SC_070
ID050	224	459	1	1	280	174	0.617	low	0.67	high	63.6	LUAD	2	1	0	NA	1	2	Pembrolizumab	IO_SC_075
ID051	77	1253	1	1	346	101	0.774	high	0.678	high	60.7	LUSC	0	1	0	3	1	2	Pembrolizumab	IO_SC_076
ID052	35	90	1	1	577	103	0.849	high	0.768	high	77.5	LUAD	1	1	0	0	0	1	Atezolizumab	IO_SC_077
ID053	35	443	1	1	656	269	0.709	high	0.749	high	67.9	LUAD	1	1	0	0	1	1	Atezolizumab	IO_SC_078
ID054	56	438	1	1	58	126	0.315	low	0.315	low	63.4	LUSC	0	1	0	0	0	1	Atezolizumab	IO_SC_079
ID055	35	127	1	1	288	368	0.439	low	0.444	low	60.2	LUAD	1	1	0	10	0	1	Atezolizumab	IO_SC_080
ID056	255	302	1	1	353	379	0.482	low	0.764	high	61.4	Others	3	1	0	0	0	1	Atezolizumab	IO_SC_083
ID057	56	650	1	1	260	261	0.499	low	0.495	low	71.5	LUAD	1	1	0	5	0	1	Atezolizumab	IO_SC_084
ID058	35	205	1	1	347	305	0.532	low	0.781	high	71.6	Others	1	1	0	0	0	1	Atezolizumab	IO_SC_085
ID059	58	373	1	1	91	160	0.363	low	0.434	low	67	LUAD	1	1	0	0	1	1	Atezolizumab	IO_SC_088
ID060	58	144	1	1	90	237	0.275	low	0.272	low	72.5	Others	1	1	0	0	0	1	Atezolizumab	IO_SC_089
ID061	120	169	1	1	1074	324	0.768	high	0.785	high	63.4	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_090
ID062	70	120	1	1	66	232	0.221	low	0.218	low	67.2	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_093
ID063	966	966	0	1	265	260	0.505	low	0.509	low	82.2	LUSC	1	1	0	0	0	1	Atezolizumab	IO_SC_094
ID064	181	403	1	1	162	307	0.345	low	0.341	low	60.6	LUAD	1	1	1	100	1	1	Pembrolizumab	IO_SC_095
ID065	32	117	1	1	450	98	0.821	high	0.761	high	59.3	LUAD	2	1	0	0	1	2	Atezolizumab	IO_SC_107
ID066	446	446	1	1	102	146	0.411	low	0.379	low	65.9	LUAD	2	1	0	0	0	1	Atezolizumab	IO_SC_108
ID067	42	478	1	1	278	122	0.695	low	0.765	high	55.8	LUAD	1	1	0	0	0	1	Atezolizumab	IO_SC_109
ID068	34	47	1	1	570	283	0.668	low	0.483	low	57.5	LUAD	2	1	0	0	0	1	Atezolizumab	IO_SC_112
ID069	684	684	0	1	96	221	0.303	low	0.369	low	72.6	LUSC	0	1	1	60	0	1	Pembrolizumab	IO_SC_114
ID070	21	73	1	1	69	102	0.404	low	0.45	low	67.4	LUAD	1	1	0	20	0	1	Pembrolizumab	IO_SC_116
ID071	39	126	1	1	225	211	0.516	low	0.362	low	64.4	LUAD	1	1	0	0	1	1	Atezolizumab	IO_SC_118
ID072	51	198	1	1	104	174	0.374	low	0.367	low	59.6	LUAD	3	1	0	0	1	1	Nivolumab	IO_SC_126
ID073	597	1113	1	1	55	461	0.107	low	0.281	low	51.7	LUSC	0	0	1	100	0	1	Pembrolizumab	IO_SC_127